evitria offers recombinant antibody production service for industrial applications as well as for research. Here you can find all articles about evitria’s services and the benefits for companies cooperating with evitria.
In the dynamic landscape of antibody research and therapeutics, having a diverse array of purification methods is essential. At Evitria AG, we recognize the need for flexibility to meet various project requirements. Let’s delve into our updated purification services.
Delivering material with the same quality at every scale, and with several years in between campaigns, enabled our client to rapidly move through development stages without having to undertake difficult troubleshooting activities or worry about their material quality.
There can be several reasons to outsource the production of antibodies to specialized CROs and CDMOs. This article illustrates what should be considered when choosing a partner in antibody production.
CROs are an important cornerstone in the industrial production of antibodies. In this article, we will discuss their role for mAb production in detail.
CDMOs play an important role in antibody production, providing several services. In this article, we will have a look at what these services are.
In the biopharmaceutical sector, CRO is a frequently found abbreviation when it comes to outsourcing specific steps. But what does the acronym stand for?
Proteins tagged with 4-10 histidine (His) residues can be purified using Immobilized Metal Affinity Chromatography (IMAC). This technique utilizes imidazole rings present on histidine side chains to non-covalently bind to the positively charged metal ions within an IMAC resin. IMAC purification can be used to purify proteins in their native conformation as well as under denaturing conditions.
In the past 10 years, the use of bispecific antibodies – proteins capable of engaging two targets simultaneously – has become a key focus area for the industry. Read all about their success and research feasibility in this article.
In vivo or in vitro – which is the better way for antibody production? The issue is highly discussed among experts, and historically, they both have had their merit. This article will show the main differences, advantages and disadvantages of the two approaches.
Big and small companies alike find value in outsourcing to contract research organizations (CROs). A CRO takes on research, development or production assignments, thus saving the sponsor time, cost and capacities. This article will give valuable pointers to the essential factors any company must consider when screening for CROs for recombinant antibody production.